VF
PTCT icon

Virtu Financial’s PTC Therapeutics PTCT Stock Holding History

Virtu Financial’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$583K Buy
+7,147
New +$516K 0.02% 480
2024
Q1 		– Sell
-9,222
Closed -$254K – 1958
2023
Q4 		$254K Sell
9,222
-2,689
-23% -$61.5K 0.02% 686
2023
Q3 		$267K Buy
+11,911
New +$443K 0.03% 553
2022
Q3 		– Sell
-6,589
Closed -$264K – 2136
2022
Q2 		$264K Buy
+6,589
New +$231K 0.02% 640
2021
Q1 		– Sell
-8,358
Closed -$510K – 1930
2020
Q4 		$510K Buy
+8,358
New +$493K 0.06% 434
2018
Q2 		– Sell
-8,943
Closed -$242K – 2391
2018
Q1 		$242K Sell
8,943
-5,861
-40% -$149K 0.01% 1217
2017
Q4 		$247K Buy
+14,804
New +$251K 0.01% 1447

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Virtu Financial's PTCT Position: Q2 2026 in Review

Virtu Financial opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 7,147 shares worth $583K. The stake represents 0.02% of the portfolio and ranks #480 among its holdings. This is a return to the name: Virtu Financial previously reported a position in PTCT as recently as Q4 2023.

Virtu Financial first reported a position in PTCT in Q4 2017 and has held it in 7 quarters since. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Virtu Financial held 7,147 shares of PTC Therapeutics worth $583K as of Q2 2026.
  • PTC Therapeutics was a new Virtu Financial position in Q2 2026.
  • PTC Therapeutics made up 0.02% of Virtu Financial's portfolio in Q2 2026, its #480 holding.
  • Virtu Financial first reported a position in PTC Therapeutics in Q4 2017 and has held it in 7 quarters since.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.